Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
24.34
-0.34 (-1.36%)
At close: Nov 14, 2025, 4:00 PM EST
23.93
-0.41 (-1.66%)
After-hours: Nov 14, 2025, 7:35 PM EST

Rapport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22
1,162649--
Enterprise Value
660330--
Last Close Price
24.3717.74--
PB Ratio
2.272.12--
P/TBV Ratio
2.272.12--
Debt / Equity Ratio
0.020.010.050.54
Quick Ratio
35.8434.8216.7518.74
Current Ratio
36.3735.3417.1418.80
Return on Equity (ROE)
-23.41%-35.09%-43.36%-
Return on Assets (ROA)
-15.88%-22.07%-24.18%-
Return on Capital (ROIC)
-16.23%-22.86%-25.52%-
Earnings Yield
-8.41%-12.07%--
FCF Yield
-6.71%-10.36%--
Buyback Yield / Dilution
-190.80%-1277.25%-93.74%-
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q